Follow The Filings

CLOV Clover Health Investments

Clover Health Investments earnings company data as of 8:15 PM ET 11/12

  • 0 of 1 EPS beats

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS 0.01 0.01 In line
Rev $738.2M $759.3M Beat +2.9%

Insider trades

Open-market buys and sales by CLOV's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CLOV insider trades
  • None no insider bought on the open market
  • $1.2M sold by 4 insiders outside a trading plan
  • $2.8M sold by 3 insiders under 10b5-1 plans
  1. Joseph Clay Thornton CFO
    Sale
    $110K 22,099 shares at $4.97 1.4% of stake
    Traded Nov 16 Filed Nov 17
  2. Karen Soares Chief Legal Officer
    Planned sale
    $90K 19,275 shares at $4.66 1.2% of stake
    Traded Oct 20 Filed Oct 20
  3. Jamie L. Reynoso CEO, Medicare Advantage
    Planned sale
    $18K 4,066 shares at $4.41 0.1% of stake
    Traded Oct 19 Filed Oct 20
  4. Jamie L. Reynoso CEO, Medicare Advantage
    Planned sale
    $9,288 2,006 shares at $4.63 0.1% of stake
    Traded Oct 7 Filed Oct 7
  5. Jamie L. Reynoso CEO, Medicare Advantage
    Planned sale
    $8,760 1,921 shares at $4.56 0.1% of stake
    Traded Sep 17 Filed Sep 18
  6. Conrad Wai CEO, Counterpart Health
    Planned sale
    $1.4M 300,000 shares at $4.72 20% of stake
    Traded Sep 15 Filed Sep 16
  7. Joseph Frank Oldakowski VP of Finance and Controller
    Sale
    $103K 20,000 shares at $5.16 6.7% of stake
    Traded Sep 14 Filed Sep 14
  8. Karen Soares Chief Legal Officer
    Planned sale
    $233K 51,700 shares at $4.51 3.3% of stake
    Traded Jul 20 Filed Jul 20
  9. Jamie L. Reynoso CEO, Medicare Advantage
    Planned sale
    $22K 4,839 shares at $4.53 0.2% of stake
    Traded Jul 17 Filed Jul 17
  10. Jamie L. Reynoso CEO, Medicare Advantage
    Planned sale
    $11K 2,384 shares at $4.68 0.1% of stake
    Traded Jul 8 Filed Jul 9
  11. Jamie L. Reynoso CEO, Medicare Advantage
    Planned sale
    $11K 2,360 shares at $4.78 0.1% of stake
    Traded Jun 17 Filed Jun 18
  12. Jamie L. Reynoso CEO, Medicare Advantage
    Planned sale
    $36K 7,289 shares at $4.91 0.3% of stake
    Traded Jun 11 Filed Jun 11
  13. Conrad Wai CEO, Counterpart Health
    Planned sale
    $879K 220,426 shares at $3.99 14% of stake
    Traded May 28 Filed May 28
  14. Carladenise Armbrister Edwards Director
    Sale
    $230K 67,160 shares at $3.42 19% of stake
    Traded May 18 Filed May 19
  15. Brady Patrick Priest CEO of Clover Care Services
    Sale
    $345K 98,039 shares at $3.52 4.6% of stake
    Traded May 13 Filed May 13

Also filed in the last 12 months, not counted as buying or selling: 31 share withholdings for taxes, 22 sales to cover taxes, 16 stock grants, and 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 10 shown.

Filed Form Detail Links
8-K 7.01,9.01
10-Q
8-K 2.02,5.02,9.01
8-K 7.01,9.01
8-K/A 5.02,9.01
8-K 5.02,9.01
8-K 7.01,9.01
10-Q
8-K 2.02,9.01
8-K 8.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf